Company Search:
Advanced Search
Sponsored Links
Armata Pharmaceuticals Inc Company Snapshot
Armata Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Armata Pharmaceuticals Inc with three other companies in this sector in the United States: Premier Biomedical Inc (2017 sales of $39,761.00 ), CEL-SCI Corporation ($69,020.00 ), and CytRx Corporation ($100,000.00 of which 100% was Pharmaceutical Product Developers).

Sales Analysis. Armata Pharmaceuticals Inc reported sales of $115,000.00 for the year ending December of 2017. This represents a sharp decrease of 55.8% versus 2016, when the company's sales were $260,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Armata Pharmaceuticals Inc
  Stock Performance Chart for Armata Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4.38
(Figures in U.S. Dollars)
1 Week 1.9%   13 Weeks 6.9%  
4 Weeks -1.6%   52 Weeks 15.9%  
Armata Pharmaceuticals Inc Key Data:
  Ticker: ARMP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 115,000
(Year Ending Jan 2018).
Employees: 31
  Currency: U.S. Dollars Market Cap: 43,512,230
  Fiscal Yr Ends: December Shares Outstanding: 9,934,299
  Share Type: Common Closely Held Shares: 2,253,198
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.